WANG LAW FIRM Let a former scientist handle your immigration affairs
Sample Cases (Aliens of extraordinary ability) EB1A-297: The petitioner/beneficiary was a bioinformatics scientist (bioinformatics, genomics, genetics, biotechnology) and worked at a US biotechnology company. He earned his Ph.D. in the United States and published 14 journal research articles. These publications were cited over 1300 times. The petition was filed in 2020 and approved two weeks later (No RFE). EB1A-296: The petitioner/beneficiary was a biomedical scientist (cancer research) and worked at a US medical school and research hospital. She earned her Ph.D. in China and published over ten journal research articles. These publications were cited over 400 times. The petition was filed in 2020 and approved two weeks later (No RFE). EB1A-295: The petitioner/beneficiary was a chemical scientist (chemical compound synthesis) and worked at a small US chemical company. He earned his Ph.D. in the United States and published ten journal research articles. These publications were widely cited by others. The petition was filed in 2020 and approved two weeks later (No RFE). EB1A-294: The petitioner/beneficiary was a biomedical scientist (psychology) and worked at a US medical school. She earned her Ph.D. in the United States and published 11 journal research articles. These publications were moderately cited (<400 times) by others. The petition was filed in 2020 and approved two weeks later (No RFE). EB1A-293: The petitioner/beneficiary was a biochemical scientist (structural biology) and worked at a US private research hospital. She earned her Ph.D. China and published seven journal research articles. These publications were widely cited (>600 times) by others. The petition was filed in 2020 and approved two weeks later (No RFE). EB1A-292: The petitioner/beneficiary was a biomedical scientist (cancer research, non-coding RNA) and worked at a US public university. He earned his Ph.D. in China and published 22 journal research articles. These publications were very widely cited (>2500 times) by others. The petition was filed in 2020 and approved two weeks later (No RFE). EB1A-291: The petitioner/beneficiary was a biomedical scientist (cancer research) and worked at a US private research hospital. He earned his Ph.D. in the United States and published nine journal research articles. These publications were widely cited by others. The petition was filed in 2019 and approved two weeks later (No RFE). EB1A-290: The petitioner/beneficiary was a chemical and materials scientist (biotechnology) and worked at a US private research institute. He earned his Ph.D. in the United States and published over ten journal research articles. These publications were widely cited by others. The petition was filed in 2019 and approved two weeks later (No RFE). EB1A-289: The petitioner/beneficiary was a biomedical scientist (cell reprogramming, genomics) and worked at a US private research institute. He earned his Ph.D. in China and published six journal research articles. These publications were widely cited by others. The petition was filed in 2019 and approved two weeks later (No RFE). EB1A-288: The petitioner/beneficiary was a biomedical scientist (cancer research) and worked at a US public university. He earned his Ph.D. in the United States and published over twenty journal research articles. These publications were widely cited by others. The petition was filed in 2018 and approved two weeks later (No RFE). EB1A-287: The petitioner/beneficiary was a chemical scientist (analytical chemistry) and worked at a US biopharmaceutical company. She earned her Ph.D. in the United States and published about ten journal research articles. These publications were moderately cited by others. The petition was filed in 2018 and approved two weeks later (No RFE). EB1A-286: The petitioner/beneficiary was a biomedical scientist (eye disease) and worked at a US private university. She earned her Ph.D. in China and published over ten journal research articles. These publications were moderately cited by others. The petition was filed in 2018 and approved three months later (After RFE). EB1A-285: The petitioner/beneficiary was a biomedical scientist (hypertension, gut microbiota ) and worked at a US public university. He earned his Ph.D. in the United States and published over ten journal research articles. These publications were moderately cited by others. The petition was filed in 2018 and approved two weeks later (No RFE). EB1A-284: The petitioner/beneficiary was a biomedical scientist (human genetics, gene mutations) and worked at a US research hospital. He earned his Ph.D. in China and published twenty journal research articles. These publications were moderately cited by others. The petition was filed in 2018 and approved two weeks later (No RFE). EB1A-283: The petitioner/beneficiary was a biomedical scientist (biochemistry, molecular biology, protein structure) and worked at a US medical school. He earned his Ph.D. in the United States and published six journal research articles. These publications were widely cited by others. The petition was filed in 2017 and approved one year later (after RFE). EB1A-282: The petitioner/beneficiary was a biomedical scientist (neuroscience, pain research) and worked at a US private university. She earned her Ph.D. in China and published ten journal research articles. These publications were moderately cited by others. The petition was filed in 2018 and approved two weeks later (No RFE). EB1A-281: The petitioner/beneficiary was a pharmaceutical scientist (pharmacology, population pharmacokinetics) and worked at a major pharmaceutical company. She received undergraduate education in China and earned her Ph.D. in the United States. The petitioner published 13 journal research articles. Some publications were widely cited by others. The petition was filed in 2018 and approved two weeks later (No RFE). EB1A-280: The petitioner/beneficiary was a biomedical scientist (brain disease, neuroscience) and worked at a US medical school and private hospital. He received his Ph.D. in the United States and published seven journal research articles. These publications were moderately cited by others. The petition was filed in 2018 and approved two weeks later (No RFE). EB1A-279: The petitioner/beneficiary was a computer scientist (bioinformatics, computational biology) and worked at a US medical school. He earned his Ph.D. in Computer Science in China and received postdoctoral training in the United States. The petitioner co-authored and published some research articles and book chapters in Chinese and English. These publications were moderately cited by others. The petition was filed in 2018 and approved two weeks later (No RFE). EB1A-278: The petitioner/beneficiary was a scientist in biomedical engineering (single cell mechanobiology, tissue engineering) and worked at a US public university. She received her Ph.D. in the United States and published over ten journal research articles. These publications were widely cited by others. The petition was filed in 2018 and approved two weeks later (No RFE). EB1A-277: The petitioner/beneficiary was a medical scientist (stem cell therapy) and worked at a US medical school. She received her Ph.D. in China and published eight journal research articles. These publications were moderately cited by others. The petition was filed in 2018 and approved two weeks later (No RFE). EB1A-276: The petitioner/beneficiary was a biomedical scientist (insect immunology, immunology) and worked at a US medical school. She received her Ph.D. in the United States and published over 10 research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved four months later (after RFE). EB1A-275: The petitioner/beneficiary was a biomedical scientist (autophagy) and worked at a US public university. She received her Ph.D. in the United States and published over 10 journal research articles. These publications were widely cited by others. The petition was filed in 2018 and approved two weeks later (No RFE). EB1A-274: The petitioner/beneficiary was a biological scientist (neuroscience) and worked at a US private university. He received Ph.D. in the United States and published over several journal research articles. These publications were moderately cited by others. The petition was filed in 2018 and approved one week later (No RFE). EB1A-278: The petitioner/beneficiary was a scientist in biomedical engineering (single cell mechanobiology, tissue engineering) and worked at a US public university. She received her Ph.D. in the United States and published over 10 research articles. These publications were widely cited by others. The petition was filed in 2018 and approved two weeks later (No RFE). EB1A-273: The petitioner/beneficiary was a chemical scientist (organic chemistry) and worked at a US medical school. He received Ph.D. in China and published about 10 research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE). EB1A-272: The petitioner/beneficiary was a medical scientist (stem cell, biomedical engineering) and worked at a US medical school. He received Ph.D. in China and published about 10 research articles. Some publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE). EB1A-271: The petitioner/beneficiary was a medical scientist (HCV, cell reprogramming) and worked at a US medical school. She received Ph.D. in the United States and published over 10 research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE). EB1A-270: The petitioner/beneficiary was a medical scientist (neuroscience, neurodegenerative disease) and worked at a US medical school. He received Ph.D. in China and published over 10 research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE). EB1A-269: The petitioner/beneficiary was a biological scientist (autophagy) and worked at a US public university. He received Ph.D. in the United States and published over 10 research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (after RFE). EB1A-268: The petitioner/beneficiary was a medical scientist (stem cells, cancer, epigenetics) and worked at a US medical school. He received Ph.D. in China and published over 10 research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE). EB1A-267: The petitioner/beneficiary was a medical scientist (human medical genetics, RNA biology) and worked at a US medical school. He received Ph.D. in China and published over 50 research articles. These publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE). EB1A-266: The petitioner/beneficiary was a chemical scientist (natural products, drug development, biomaterials) and worked at a US medical school. He received Ph.D. in Hong Kong and published over 10 research articles. These publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE). EB1A-265: The petitioner/beneficiary was a mathematical scientist (computational mathematics) and worked at an Associate Professor at a US public university. He received Ph.D. in the United States and published over 50 research articles. These publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE). EB1A-264: The petitioner/beneficiary was a chemical scientist (analytical chemistry, proteomics, mass spectrometry, etc.) and worked at a US private university. He received Ph.D. in China and published over 30 research articles. These publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE). EB1A-263: The petitioner/beneficiary was a biomedical scientist (obesity, diabetes, adipose tissue, stress response, nutritional science) and worked at a US medical school. He received Ph.D. in China and published about twenty research articles. These publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE). EB1A-262: The petitioner/beneficiary was a neuroscientist (memory and learning, sexual behavior) and worked at a US medical school. He received Ph.D. in Austria and published over ten research articles. These publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE). EB1A-261: The petitioner/beneficiary was a materials scientist (battery) and worked at a US national laboratory. He received Ph.D. in the United States and published nine research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE). EB1A-260: The petitioner/beneficiary was a biomedical scientist (maternal diabetes, cardiovascular disease) and worked at a US public university. She received Ph.D. in China and published about twenty research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE). EB1A-259: The petitioner/beneficiary was a biophysicist and biomedical scientist (biophysics, biomedical engineering, etc.) and worked at a US public university. He received M.S. in China and Ph.D. in the United States and published over ten research articles. These publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE). EB1A-258: The petitioner/beneficiary was a biomaterials scientist (biomedical and mechanical engineering) and worked at a US public university. He received Ph.D. in Canada and published over ten research articles. These publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE). EB1A-257: The petitioner/beneficiary was a biochemist (traditional Chinese medicine, cardiovascular disease) and worked at a US medical school. He received Ph.D. in China and published about ten research articles. These publications were modestly cited by others. The petition was filed in 2017 and approved two weeks later (No RFE). EB1A-256: The petitioner/beneficiary was a biomedical scientist (developmental biology, stem cells) and worked at a US public university. She received Ph.D. in China and published seventeen research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE). EB1A-255: The petitioner/beneficiary was a biomedical scientist (skin disease, melanoma, prostate cancer) and worked at a US public university. He received Ph.D. in Sweden and published about twenty research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE). EB1A-254: The petitioner/beneficiary was a biomedical scientist (cancer research) and worked at a US public university. He received Ph.D. in China and published over ten research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE). EB1A-253: The petitioner/beneficiary was a biomedical scientist (RNA biology, X chromosome inactivation) and worked at a US medical school. He received Ph.D. in the United States and published eight research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE). EB1A-252: The petitioner/beneficiary was a biomedical scientist (cancer research) and worked at a US medical school. He received Ph.D. in China and published over twenty research articles. These publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE). EB1A-251: The petitioner/beneficiary was a biomedical scientist (genomics, bioinformatics, stem cells) and worked at a US medical school. He received Ph.D. in China and published over ten research articles. These publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).
|